CARR EDWARD (CHIEF ACCOUNTING OFFICER) sold 20K shares of DIANTHUS THERAPEUTICS, INC. /DE/ on the open market
Open‑market sale worth $2.03M. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+20K
Price / share
$17.88
Trade value
$357.60K
% of position
Common Stock
Shares
−7.93K
Price / share
$100.43
Trade value
$796.21K
% of position
Common Stock
Shares
−6.77K
Price / share
$101.37
Trade value
$686.38K
% of position
Common Stock
Shares
−3.50K
Price / share
$102.39
Trade value
$358.47K
% of position
Common Stock
Shares
−1.10K
Price / share
$103.20
Trade value
$113.52K
% of position
Common Stock
Shares
−700.00
Price / share
$104.39
Trade value
$73.07K
% of position
Net shares
+0.00
Net value
-$1.67M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/17/2026 | M · Option Exercise | +20K | $17.88 | $357.60K | New position | 0.00 | 20K |
| Common Stock Direct | 9/17/2026 | S · Sale | −7.93K | $100.43 | $796.21K | 39.6% | 20K | 12.07K |
| Common Stock Direct | 9/17/2026 | S · Sale | −6.77K | $101.37 | $686.38K | 56.1% | 12.07K | 5.30K |
| Common Stock Direct | 9/17/2026 | S · Sale | −3.50K | $102.39 | $358.47K | 66.0% | 5.30K | 1.80K |
| Common Stock Direct | 9/17/2026 | S · Sale | −1.10K | $103.20 | $113.52K | 61.1% | 1.80K | 700.00 |
| Common Stock Direct | 9/17/2026 | S · Sale | −700.00 | $104.39 | $73.07K | New position | 700.00 | 0.00 |
| Total | +0.00 | -$1.67M | ||||||
Stock Option (Right to Buy)
Common Stock
20K shares
Shares
−20K
Strike price
17.88
Held after
43.82K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock20K shares | 9/17/2026 | M · Option Exercise | −20K | 17.88 | — | 43.82K |